|
Supplemental Material
|
|
Supplemental Figure 6:
Expression of Olig1 and Olig2 in normal and malignant brain samples.
(Also available in
Portable Document Format [PDF] )
|
|
|
Supplemental Figure 7:
Stereotactic biopsy samples from different regions of the same GBM tumor display
divergent histologies.
| File desc: |
Link |
| Supp. Fig.7
HTML |
HTML |
| Supp. Fig.7
PDF |
PDF |
| Tumor 5 64A34
Close-up |
JPG |
| Tumor 5 69A34
Close-up |
JPG |
| Tumor 6 25A35
Close-up |
JPG |
| Tumor 6 79A34
Close-up |
JPG |
| Tumor 7 62A34
Close-up |
JPG |
| Tumor 7 76A34
Close-up |
JPG |
| Tumor 9 6A35
Close-up |
JPG |
| Tumor 9 36A35
Close-up |
JPG |
|
|
|
Supplemental Table 1:
Clinical parameters for patients in the two sub-groups of GBM identified
by microarray analysis.
(Available in
Portable Document Format [PDF] )
|
|
|
Supplemental Figure 8:
FABP7 protein levels correlate with microarray gene expression measurements.
| File desc: |
Link |
| Supp. Fig.8
HTML |
HTML |
| Supp. Fig.8
PDF |
PDF |
| Tumor 41A41
Close-up |
JPG |
| Tumor 70P
Close-up |
JPG |
| Tumor 32A6
Close-up |
JPG |
| Tumor 52A28
Close-up |
JPG |
| Tumor 46A15
Close-up |
JPG |
| Tumor 4A10
Close-up |
JPG |
|
|
Supplemental Figure 9:
FABP7 protein expression in an independent cohort of GBM patients.
| File desc: |
Link |
| Supp. Fig.9
HTML |
HTML |
| Supp. Fig.9
PDF |
PDF |
| Sup.Fig.9A
Close-up |
JPG |
| Sup.Fig.9B
Close-up |
JPG |
| Sup.Fig.9C
Close-up |
JPG |
| Sup.Fig.9D
Close-up |
JPG |
|
|
|
Supplemental Table 2:
Results of cox survival analysis for all genes in Figure 1B. Calculations were done using the R statistical package and
p values are uncorrected.
| File desc: |
Link |
| Supp. Table 2
|
TXT |
|
| |
